We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
Read MoreHide Full Article
Veeva Systems (VEEV - Free Report) ended the recent trading session at $193.09, demonstrating a -1.89% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.38%. Elsewhere, the Dow saw an upswing of 0.02%, while the tech-heavy Nasdaq appreciated by 0.9%.
The stock of provider of cloud-based software services for the life sciences industry has risen by 21.36% in the past month, leading the Medical sector's gain of 4.34% and the S&P 500's gain of 1.27%.
Investors will be eagerly watching for the performance of Veeva Systems in its upcoming earnings disclosure. On that day, Veeva Systems is projected to report earnings of $2.22 per share, which would represent year-over-year growth of 11.56%. Alongside, our most recent consensus estimate is anticipating revenue of $904.07 million, indicating a 14.57% upward movement from the same quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $9.05 per share and a revenue of $3.64 billion, indicating changes of +11.73% and +13.96%, respectively, from the former year.
Investors might also notice recent changes to analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Currently, Veeva Systems is carrying a Zacks Rank of #3 (Hold).
Digging into valuation, Veeva Systems currently has a Forward P/E ratio of 21.75. This signifies a discount in comparison to the average Forward P/E of 28.61 for its industry.
Also, we should mention that VEEV has a PEG ratio of 0.62. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical Info Systems industry had an average PEG ratio of 3.19 as trading concluded yesterday.
The Medical Info Systems industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 100, positioning it in the top 41% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
Veeva Systems (VEEV - Free Report) ended the recent trading session at $193.09, demonstrating a -1.89% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.38%. Elsewhere, the Dow saw an upswing of 0.02%, while the tech-heavy Nasdaq appreciated by 0.9%.
The stock of provider of cloud-based software services for the life sciences industry has risen by 21.36% in the past month, leading the Medical sector's gain of 4.34% and the S&P 500's gain of 1.27%.
Investors will be eagerly watching for the performance of Veeva Systems in its upcoming earnings disclosure. On that day, Veeva Systems is projected to report earnings of $2.22 per share, which would represent year-over-year growth of 11.56%. Alongside, our most recent consensus estimate is anticipating revenue of $904.07 million, indicating a 14.57% upward movement from the same quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $9.05 per share and a revenue of $3.64 billion, indicating changes of +11.73% and +13.96%, respectively, from the former year.
Investors might also notice recent changes to analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Currently, Veeva Systems is carrying a Zacks Rank of #3 (Hold).
Digging into valuation, Veeva Systems currently has a Forward P/E ratio of 21.75. This signifies a discount in comparison to the average Forward P/E of 28.61 for its industry.
Also, we should mention that VEEV has a PEG ratio of 0.62. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical Info Systems industry had an average PEG ratio of 3.19 as trading concluded yesterday.
The Medical Info Systems industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 100, positioning it in the top 41% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.